東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Ocular pharmacology." ]

切換: 標籤 | MARC模式 | ISBD

Ophthalmic product development = fro...

Neervannan, Seshadri.

FindBook

Google Book

Amazon

博客來

Ophthalmic product development = from bench to bedside /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Ophthalmic product development/ edited by Seshadri Neervannan, Uday B. Kompella.
其他題名:	from bench to bedside /
其他作者:	Neervannan, Seshadri.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	1 online resource (ix, 650 p.) :ill., digital ;24 cm.
內容註:	Introduction and History of Ophthalmic Product Development -- Ocular Surface Anatomy and Physiology: Impact on Product Development -- Anatomy and Physiology of the Anterior Chamber - Impact on Product Development -- Back of the eye anatomy & physiology - Impact on product development -- Physicochemical and Biological Fundamentals for Drug Delivery to the Eye -- Topical Ophthalmic Dosage Form Development - Key Components and Critical Quality Attributes -- Intra-ocular Injectable Dosage Form Development -- Microbiological Considerations for Ophthalmic Products - Sterility, Endotoxin Limits and Preservatives -- Packaging Development - Multi-dose container closure for preservative free products, extractable/leachables from packaging, new technologies -- Liquid ophthalmic drug products - physicochemical properties, formulations and manufacturing considerations -- Emulsions for topical eye delivery: state of the art and future perspectives -- Emulsions for topical eye delivery: state of the art and future perspectives -- Microparticle Products For The Eye - preformulation, formulation, and manufacturing considerations -- NANOPARTICLE PRODUCTS FOR THE EYE: preformulation, formulation and manufacturing considerations -- Advanced Hydrogel Formulations for the Eye -- Ophthalmic Product Development for Biologics -- Implantable Devices to Treat Ophthalmic Conditions -Drug Delivery Systems -- Development of Artificial Tears Products for Ocular Conditions -- Approval of Topical Ophthalmic Generic Products in the US - Simple to Complex Dosage Forms and Establishing Equivalency -- The development and commercialization of sustained-release ocular drug delivery technologies -- Manufacturing considerations and challenges for AAV Ocular Gene Therapy -- Transcorneal Kinetics of Topical Drugs and Nanoparticles.
Contained By:	Springer Nature eBook
標題:	Ophthalmic drugs. -
電子資源:	https://doi.org/10.1007/978-3-030-76367-1
ISBN:	9783030763671

Ophthalmic product development = from bench to bedside /
Ophthalmic product developmentfrom bench to bedside /[electronic resource] :edited by Seshadri Neervannan, Uday B. Kompella. - Cham :Springer International Publishing :2021. - 1 online resource (ix, 650 p.) :ill., digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,372210-738X ;. - AAPS advances in the pharmaceutical sciences series ;37..

Introduction and History of Ophthalmic Product Development -- Ocular Surface Anatomy and Physiology: Impact on Product Development -- Anatomy and Physiology of the Anterior Chamber - Impact on Product Development -- Back of the eye anatomy & physiology - Impact on product development -- Physicochemical and Biological Fundamentals for Drug Delivery to the Eye -- Topical Ophthalmic Dosage Form Development - Key Components and Critical Quality Attributes -- Intra-ocular Injectable Dosage Form Development -- Microbiological Considerations for Ophthalmic Products - Sterility, Endotoxin Limits and Preservatives -- Packaging Development - Multi-dose container closure for preservative free products, extractable/leachables from packaging, new technologies -- Liquid ophthalmic drug products - physicochemical properties, formulations and manufacturing considerations -- Emulsions for topical eye delivery: state of the art and future perspectives -- Emulsions for topical eye delivery: state of the art and future perspectives -- Microparticle Products For The Eye - preformulation, formulation, and manufacturing considerations -- NANOPARTICLE PRODUCTS FOR THE EYE: preformulation, formulation and manufacturing considerations -- Advanced Hydrogel Formulations for the Eye -- Ophthalmic Product Development for Biologics -- Implantable Devices to Treat Ophthalmic Conditions -Drug Delivery Systems -- Development of Artificial Tears Products for Ocular Conditions -- Approval of Topical Ophthalmic Generic Products in the US - Simple to Complex Dosage Forms and Establishing Equivalency -- The development and commercialization of sustained-release ocular drug delivery technologies -- Manufacturing considerations and challenges for AAV Ocular Gene Therapy -- Transcorneal Kinetics of Topical Drugs and Nanoparticles.

This is a comprehensive textbook addressing the unique aspects of drug development for ophthalmic use. Beginning with a perspective on anatomy and physiology of the eye, the book provides a critical appraisal of principles that underlie ocular drug product development. The coverage encompasses topical and intraocular formulations, small molecules and biologics (including protein and gene therapies), conventional formulations (including solutions, suspensions, and emulsions), novel formulations (including nanoparticles, microparticles, and hydrogels), devices, and specialty products. Critical elements such as pharmacokinetics, influence of formulation technologies and ingredients, as well as impact of disease conditions on products development are addressed. Products intended for both the front and the back of the eye are discussed with an eye towards future advances.

ISBN: 9783030763671

Standard No.: 10.1007/978-3-030-76367-1doiSubjects--Topical Terms:

916270
Ophthalmic drugs.

LC Class. No.: RE994

Dewey Class. No.: 615.19

Ophthalmic product development = from bench to bedside /
LDR:03804nmm a2200337 a 4500 001 2262245
003 DE-He213
005 20220220172629.0
006 m o d
007 cr nn 008maaau
008 220616s2021 sz s 0 eng d
020 $a 9783030763671 $q (electronic bk.)
020 $a 9783030763664 $q (paper)
024 7 $a 10.1007/978-3-030-76367-1 $2 doi
035 $a 978-3-030-76367-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RE994
072 7 $a PSB $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a PNB $2 thema
082 0 4 $a 615.19 $2 23
090 $a RE994 $b .O61 2021
245 0 0 $a Ophthalmic product development $h [electronic resource] : $b from bench to bedside / $c edited by Seshadri Neervannan, Uday B. Kompella.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a 1 online resource (ix, 650 p.) : $b ill., digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-738X ; $v 37
505 0 $a Introduction and History of Ophthalmic Product Development -- Ocular Surface Anatomy and Physiology: Impact on Product Development -- Anatomy and Physiology of the Anterior Chamber - Impact on Product Development -- Back of the eye anatomy & physiology - Impact on product development -- Physicochemical and Biological Fundamentals for Drug Delivery to the Eye -- Topical Ophthalmic Dosage Form Development - Key Components and Critical Quality Attributes -- Intra-ocular Injectable Dosage Form Development -- Microbiological Considerations for Ophthalmic Products - Sterility, Endotoxin Limits and Preservatives -- Packaging Development - Multi-dose container closure for preservative free products, extractable/leachables from packaging, new technologies -- Liquid ophthalmic drug products - physicochemical properties, formulations and manufacturing considerations -- Emulsions for topical eye delivery: state of the art and future perspectives -- Emulsions for topical eye delivery: state of the art and future perspectives -- Microparticle Products For The Eye - preformulation, formulation, and manufacturing considerations -- NANOPARTICLE PRODUCTS FOR THE EYE: preformulation, formulation and manufacturing considerations -- Advanced Hydrogel Formulations for the Eye -- Ophthalmic Product Development for Biologics -- Implantable Devices to Treat Ophthalmic Conditions -Drug Delivery Systems -- Development of Artificial Tears Products for Ocular Conditions -- Approval of Topical Ophthalmic Generic Products in the US - Simple to Complex Dosage Forms and Establishing Equivalency -- The development and commercialization of sustained-release ocular drug delivery technologies -- Manufacturing considerations and challenges for AAV Ocular Gene Therapy -- Transcorneal Kinetics of Topical Drugs and Nanoparticles.
520 $a This is a comprehensive textbook addressing the unique aspects of drug development for ophthalmic use. Beginning with a perspective on anatomy and physiology of the eye, the book provides a critical appraisal of principles that underlie ocular drug product development. The coverage encompasses topical and intraocular formulations, small molecules and biologics (including protein and gene therapies), conventional formulations (including solutions, suspensions, and emulsions), novel formulations (including nanoparticles, microparticles, and hydrogels), devices, and specialty products. Critical elements such as pharmacokinetics, influence of formulation technologies and ingredients, as well as impact of disease conditions on products development are addressed. Products intended for both the front and the back of the eye are discussed with an eye towards future advances.
650 0 $a Ophthalmic drugs. $3 916270
650 0 $a Ocular pharmacology. $3 1362845
650 1 4 $a Pharmaceutics. $3 3538434
650 2 4 $a Ophthalmology. $3 862704
650 2 4 $a Drug Delivery. $3 3531319
650 2 4 $a Structure-Based Drug Design. $3 3538435
700 1 $a Neervannan, Seshadri. $3 3538432
700 1 $a Kompella, Uday B. $3 909700
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 37. $3 3538433
856 4 0 $u https://doi.org/10.1007/978-3-030-76367-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)